Wednesday, July 8, 2026

pharma · Atopic Dermatitis · Alopecia Areata

Forteo

Forteo patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Las Vegas, USA HQ
20 Employees
PMDA registrant Type
Company details
Status
Public
HQ
Las Vegas, USA
Employees
20
Programs
5
Drugs
0
Patents
3
Intelligence · Patents

Forteo patents

3 pharmaceutical patents indexed for Forteo. 0 expire within 24 months.

Forteo has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 11891389

    PGDH inhibitors and methods of making and using

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11345702

    PGDH inhibitors and methods of making and using

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 10973841

    Compositions for the treatment of skin conditions

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Forteo have?

3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Forteo patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.